Skip to content
Search

Latest Stories

Atif Saddiq to lead RPS's advisory group for younger pharmacists

The Royal Pharmaceutical Society (RPS)'s has appointed Atif Saddiq to chair its Early Careers Pharmacist Advisory Group on a three-year term.

Saddiq, a portfolio pharmacist in General Practice, is currently working as a lecturer at the University of Bradford.


Commenting on his appointment as the first chair of the group, he said: “I am delighted to have been appointed as Chair. We will work to help provide direction for our peers to allow them to achieve their ambitions.

“We often hear that pharmacists feel frustrated not always being able to use the breadth of their core skills and knowledge. This group will create new opportunities for younger pharmacists and provide guidance to inspire, inform and involve them in creating a professionally rewarding future."

The advisory group will provide external representation for early career pharmacists to ensure that they are recognised as crucial stakeholders in the pharmacy sector across England, Scotland and Wales.

Gail Fleming, Director of Education at RPS, said: “The group is going to play an important role in helping to shape the future of our profession and I am confident that Atif’s tenure will meet the core values of the RPS and represent our early career pharmacists to the best of his ability.”

RPS is also creating a wider reference group of early careers pharmacists which will work alongside the advisory group.

It will help identify needs around professional development, practice support and advocacy, as well as acting as a source of expertise, advice and opinion to inform RPS policy decisions and operational delivery plans, the RPS has said.

More For You

Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less